Latest Manufacturing News

Fisher & Paykel Healthcare anticipates increased costs from newly imposed US tariffs on imports from Mexico and China, potentially delaying its gross margin recovery timeline but expects no immediate profit impact for FY2025.

Lithium Energy Limited has secured unconditional shareholder approval for the amended sale of its Solaroz Lithium Brine Project, with completion now staged over two tranches through January 2026. Meanwhile, the company prepares for the Axon Graphite spin-out IPO, navigating an ongoing ASX trading suspension due to operational thresholds.

Rewardle Holdings Limited reported a robust net cash inflow from operating activities of $3.98 million for Q4 2024, offsetting significant investing outflows and ending the quarter with $1.23 million in cash.

Yowie Group’s Q2 FY25 results reveal a mixed performance with a 33% revenue drop in North America offset by growth in Australia and ongoing cost optimisation efforts.

Argent BioPharma reports strategic cost-cutting moves including facility closures and delisting from the LSE, while securing German distribution approval and raising significant capital to support its drug pipeline.

Skin Elements Limited reports steady progress in commercialising its plant-based SE Formula biotechnology, highlighted by ongoing product trials, a successful R&D rebate, and a $513k non-renounceable entitlement issue.

K-TIG Limited reports steady cash receipts and operational efficiencies while progressing a strategic acquisition and a significant capital raise to fuel growth.

European Metals Holdings Limited has clarified its recent Concept Study results for the Cinovec lithium project, retracting previous production targets while highlighting a potential increase in production capacity pending Definitive Feasibility Study confirmation.

Traffic Technologies reports a robust order book with long-term contracts and significant cost reductions, despite ongoing working capital challenges.

Cadoux Limited reports significant progress in its high purity alumina and Minhub rare earths projects, alongside robust environmental, social, and governance initiatives.

Merino & Co’s successful IPO has injected $6.35 million into the company, enabling a strategic expansion of manufacturing capacity and securing a new facility in Western Australia. The company is now poised to scale globally with automated production and enhanced distribution capabilities.

Cardiex has kicked off deliveries of its CONNEQT Pulse arterial health monitors in the U.S., reporting strong preorder momentum and a 150% sales increase in December. The company’s strategic operational shifts and pharma partnerships set the stage for sustained growth in 2025.